New Alzheimer's studies reveal disease biology, risk for progression and the potential for a novel blood test
The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular pathology is considered a major reason that treatments fail in clinical trials. Previous research ...
Sep 18, 2024
0
0